This prospective, open-label study will be conducted in 15 healthy subjects per clinical site ages 14 or older who meet the inclusion/exclusion criteria. Each subject may have up to 5 lesions treated on the face, chest or back with the Acleara insert. Subjects will receive up to 3 follow up visits and evaluated for improvement in acne lesions and monitored for any adverse events.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
30
Charles County Dermatology Associates
White Plains, Maryland, United States
Bellaire Dermatology Associates
Bellaire, Texas, United States
Subject assessment of reduction in acne lesion size
Percentage range of lesion reduction
Time frame: 24-72 hours, 1-2 weeks, 1 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.